Search research articles
Contact Us
Filters
Showing results (121-130 of 225) with videos related to
Page
of 23
Sort By:
Antimicrobial Agents and Chemotherapy
|
July 29, 2009
Culture medium composition affects the lethality of Cunninghamella bertholletiae in a fly model of mucormycosis
Georgios N Pongas, Ronen Ben-Ami, Russell E Lewis, et al.
Clinical Therapeutics
|
November 24, 2007
Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study
Georgios Chamilos, Mario Luna, Russell E Lewis, et al.
Antimicrobial Agents and Chemotherapy
|
March 5, 2014
Effectiveness of primary anti-Aspergillus prophylaxis during remission induction chemotherapy of acute myeloid leukemia
Marisa Z R Gomes, Ying Jiang, Victor E Mulanovich, et al.
Antimicrobial Agents and Chemotherapy
|
November 27, 2013
Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011
Marisa Z R Gomes, Victor E Mulanovich, Y Jiang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 17, 2012
How does antifungal pharmacology differ for mucormycosis versus aspergillosis?
Russell E Lewis, Olivier Lortholary, Brad Spellberg, et al.
The Journal of Infectious Diseases
|
April 6, 2021
Reply to Day et al
Melissa D Johnson, Russell E Lewis, Elizabeth S Dodds Ashley, et al.
Antimicrobial Agents and Chemotherapy
|
December 30, 2009
Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis
Russell E Lewis, Nathan D Albert, Guangling Liao, et al.
The Journal of Infection
|
November 22, 2011
Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer
Maria N Chitasombat, Diamantis P Kofteridis, Ying Jiang, et al.
The Journal of Antimicrobial Chemotherapy
|
January 26, 2013
High-dose induction liposomal amphotericin B followed by de-escalation is effective in experimental Aspergillus terreus pneumonia
Russell E Lewis, Nathaniel P Albert, Guangling Liao, et al.
The Journal of Infectious Diseases
|
December 18, 2012
Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosis
Russell E Lewis, Ronen Ben-Ami, Leyla Best, et al.
Page
of 23
Search research articles
Search
Showing results (121-130 of 225) with videos related to
Sort By:
Page
of 23
Antimicrobial Agents and Chemotherapy
|
July 29, 2009
Culture medium composition affects the lethality of Cunninghamella bertholletiae in a fly model of mucormycosis
Georgios N Pongas, Ronen Ben-Ami, Russell E Lewis, et al.
Clinical Therapeutics
|
November 24, 2007
Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study
Georgios Chamilos, Mario Luna, Russell E Lewis, et al.
Antimicrobial Agents and Chemotherapy
|
March 5, 2014
Effectiveness of primary anti-Aspergillus prophylaxis during remission induction chemotherapy of acute myeloid leukemia
Marisa Z R Gomes, Ying Jiang, Victor E Mulanovich, et al.
Antimicrobial Agents and Chemotherapy
|
November 27, 2013
Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011
Marisa Z R Gomes, Victor E Mulanovich, Y Jiang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 17, 2012
How does antifungal pharmacology differ for mucormycosis versus aspergillosis?
Russell E Lewis, Olivier Lortholary, Brad Spellberg, et al.
The Journal of Infectious Diseases
|
April 6, 2021
Reply to Day et al
Melissa D Johnson, Russell E Lewis, Elizabeth S Dodds Ashley, et al.
Antimicrobial Agents and Chemotherapy
|
December 30, 2009
Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis
Russell E Lewis, Nathan D Albert, Guangling Liao, et al.
The Journal of Infection
|
November 22, 2011
Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer
Maria N Chitasombat, Diamantis P Kofteridis, Ying Jiang, et al.
The Journal of Antimicrobial Chemotherapy
|
January 26, 2013
High-dose induction liposomal amphotericin B followed by de-escalation is effective in experimental Aspergillus terreus pneumonia
Russell E Lewis, Nathaniel P Albert, Guangling Liao, et al.
The Journal of Infectious Diseases
|
December 18, 2012
Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosis
Russell E Lewis, Ronen Ben-Ami, Leyla Best, et al.
Page
of 23